TrialJournal of neurology, neurosurgery, and psychiatry1999

Randomised, double blind, placebo controlled study of interferon beta-1a in relapsing-remitting multiple sclerosis analysed by area under disability/time curves.

C Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.